diagnosi
merscov
still
major
concern
daignost
laboratori
date
realtim
polymeras
chain
reaction
rtpcr
mainstay
diagnosi
merscov
rtpcr
limit
includ
long
turnaround
time
lack
common
measur
correl
viral
load
vl
recommend
screen
merscov
use
rtpcr
upstream
envelop
gene
upe
follow
confirm
presenc
one
follow
gene
open
read
frame
gene
nucleocapsid
n
gene
scientist
look
implement
viral
sequenc
neg
sampl
rtpcr
beleiv
expos
anoth
level
test
use
sequenc
rnadepend
rna
polymeras
rdrp
gene
n
gene
case
posit
result
diagnost
also
import
maintain
contin
random
sequenc
merscov
sampl
abl
pick
earli
viral
mutat
serolog
assay
still
wide
routin
perform
lot
studi
look
implement
method
routin
patient
test
confirm
case
merscov
infect
rais
question
still
unansw
detect
viru
respiratori
tract
sampl
remain
gold
standard
diagnos
merscov
infect
sever
sampl
obtain
respiratori
system
use
diagnos
merscov
infect
includ
tracheal
aspir
nasopharyng
swab
bronchoalveolar
http
lavag
sputum
tracheal
aspir
bronchoalveolar
lavag
sampl
lower
respiratori
sampl
yield
significantli
higher
viral
copi
nasopharyng
sputum
sampl
analyz
whole
blood
plasma
also
yield
posit
viral
genom
kinet
viral
presenc
blood
well
understood
observ
lymphopenia
sever
case
presenc
viru
receptor
memori
lymphocyt
warrant
studi
viral
replic
insid
lymphocyt
date
realtim
polymeras
chain
reaction
rtpcr
mainstay
diagnosi
merscov
rtpcr
limit
includ
long
turnaround
time
chiefli
due
transport
viru
test
prepar
lack
common
measur
correl
viral
load
vl
laboratori
determin
cycl
threshold
c
valu
invers
relat
viru
load
predictor
vl
diseas
progress
cut
marker
order
diagnos
case
yet
studi
evalu
whether
cycl
threshold
c
valu
associ
clinic
sever
recommend
screen
merscov
use
rtpcr
upstream
envelop
gene
upe
follow
confirm
presenc
one
follow
gene
open
read
frame
gene
nucleocapsid
n
gene
neg
sampl
rtpcr
expos
anoth
level
test
use
sequenc
rnadepend
rna
polymeras
rdrp
gene
n
gene
case
posit
result
diagnost
commerci
avail
kit
util
algorithm
test
found
highli
sensit
specif
qualiti
report
result
maintain
time
part
qualiti
program
avail
extern
profici
test
method
appli
local
korean
outbreak
later
wider
level
attempt
uncov
natur
first
isol
viru
zaki
et
al
use
random
primer
sequenc
viru
rna
sequenc
reveal
sever
open
read
frame
common
betacoronavirus
encod
mani
enzymat
product
spike
protein
smallenvelop
e
protein
matrix
protein
nucleocapsid
n
protein
seong
et
al
also
sequenc
merscov
viral
genom
four
korean
patient
mayjuli
outbreak
evid
substanti
evolutionari
chang
viru
compar
middl
eastern
sequenc
borucki
et
al
use
deep
sequenc
nasal
sampl
three
camel
infect
merscov
found
mutat
consensu
sequenc
yet
mutat
could
potenti
influenc
viru
phenotyp
impact
detect
viru
molecular
assay
assiri
et
al
sequenc
merscov
spike
gene
outbreak
taif
phylogenet
analysi
sampl
reveal
cluster
locat
within
hafralbatin
clade
close
relat
virus
isol
riyadh
outbreak
also
identifi
five
uniqu
nucleotid
substitut
spike
protein
wherea
kim
et
al
found
mutat
receptor
bind
domain
protein
merscov
isol
korea
result
reduc
affin
human
receptor
data
suggest
sequenc
merscov
like
warrant
new
subsequ
outbreak
chang
may
affect
virul
viru
addit
import
observ
locat
new
mutat
viru
gene
order
attempt
predict
effect
primer
probe
bind
site
may
influenc
diagnost
abil
current
avail
commerci
kit
acut
virus
detect
antibodi
even
antigen
might
lag
sometim
detect
viral
genom
molecular
method
kinet
antigen
product
nasopharyng
sampl
studi
far
howev
antibodi
viru
gener
appear
day
ill
onset
sever
ill
patient
requir
mechan
ventil
antibodi
delay
elisa
captur
assay
detect
np
antigen
merscov
viru
nasopharyng
sampl
develop
recent
assay
highli
sensit
detect
merscovnp
less
ngml
specif
specif
merscov
potenti
use
anim
well
song
et
al
develop
rapid
immunochromatograph
assay
detect
merscov
nucleocapsid
protein
camel
nasal
swab
sensit
specif
compar
rtrtpcr
assay
promis
worth
replic
camel
human
yet
antigen
detect
assay
wide
avail
yet
type
assay
ideal
valuabl
rule
infect
merscov
similar
sar
betacoronavirus
case
n
protein
immunogen
good
candid
develop
immun
assay
detect
viru
specif
antibodi
sever
assay
develop
detect
antibodi
merscov
includ
neutral
assay
elisa
ifa
perera
et
al
develop
microneutr
assay
detect
specif
antimerscov
antibodi
use
serial
dilut
serum
incub
vero
cellsmerscov
viru
three
day
c
score
antibodi
titer
base
viru
cpe
addit
develop
merscov
spike
pseudoparticl
neutral
assay
use
hivmer
spike
pseudoparticl
infect
vero
cell
day
infect
cell
lyse
antibodi
gave
luciferas
reduct
assign
ppna
antibodi
titer
compar
viru
neutral
assay
pseudoparticl
neutral
assay
requir
contain
indirect
fluoresc
antibodi
assay
detect
antibodi
merscov
carri
use
whole
viru
vero
cell
transfect
vero
cell
spike
nucleocapsid
protein
merscov
elisa
util
protein
also
avail
use
investig
epidemiolog
exposur
viru
far
studi
compar
elisa
detect
antimerscov
antibodi
either
ifa
neutral
assay
detect
antimerscov
antibodi
use
differ
assay
describ
still
requir
confirm
neutral
assay
techniqu
need
support
confirm
antibodi
specif
neutral
assay
wide
use
western
blot
use
sar
virus
confirm
antibodi
specif
need
western
blot
assay
case
merscov
confirm
antibodi
specif
form
genet
engin
specif
merscov
antigen
blot
membran
summari
molecular
techniqu
first
line
assay
use
confirm
merscov
infect
tracheal
aspir
bronchoalveolar
lavag
sampl
lower
respiratori
sampl
recommend
detect
viru
rtpcr
sequenc
serolog
valuabl
confirm
case
suspect
merscov
viru
detect
respiratori
sampl
fund
sourc
